Participants with ALS for Amyotrophic Lateral Sclerosis
Recruiting1 award6 criteria
Gainesville, Florida
This is a multi-site study of ALS participants and healthy controls who will undergo brain and cervical spine MRIs and NfL blood testing at up-to 4 time points over the course of a year. The primary goal is to identify objective biomarkers of disease progression that are biologically relevant, linearly progressive, and sensitive to change.
Anti-tumor antibiotic
Androgen Deprivation + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial aims to see if using a combination of adaptive androgen deprivation therapy (ADT) and Docetaxel can help in extending the period of time before prostate cancer becomes resistant to treatment.
Participants With Signs and Symptoms of Acute Coronary Syndromes for Heart Attack
Recruiting1 award10 criteria
Tampa, Florida
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Nutraceutical
Nutritional Supplement for Hangover Symptoms
Recruiting0 awardsPhase 2
St. Petersburg, Florida
This trial aims to test a nutritional supplement's effectiveness in quickly lowering blood alcohol concentration (BAC) and reducing alcohol-induced impairment and hangover symptoms. The study will involve 35 participants who will be
Popular Filters
Phase 3 Trials
Corticosteroid
Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure
Recruiting1 awardPhase 3
Melbourne, Florida
This trial will test a new medication called Baxdrostat with Dapagliflozin to see if it can improve kidney health and reduce the risk of heart problems in people with chronic kidney
Behavioural Intervention
Lumateperone for Autism
Recruiting1 awardPhase 3
Orlando, Florida
This trial is testing a new medication for irritability in children with Autism Spectrum Disorder. It will involve multiple medical centers and the participants will be randomly assigned to receive either the new medication or a placebo.
Trials Offering Remuneration
Procedure
SAP-001 for Kidney Failure
Recruiting1 awardPhase 1 & 2
Tampa, Florida
This trial will involve 32 adult participants in 4 groups, each with 8 participants, who will receive a single dose of the study drug. The study will focus on how the drug is processed in individuals with different levels of kidney function.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.